AllianceBernstein’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
Other funds holding TMCI
AC
GS
GA
CBU
AllianceBernstein's TMCI Position: Q2 2026 in Review
AllianceBernstein sold out of Treace Medical Concepts (TMCI) in Q2 2026, closing a stake of 64,550 shares — an estimated $158K sold.
AllianceBernstein first reported a position in TMCI in Q2 2021 and held it in 20 quarters. The position peaked at $87.6M in Q2 2023. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.
- AllianceBernstein reported no remaining Treace Medical Concepts position as of Q2 2026 after selling out during the quarter.
- AllianceBernstein sold 64,550 Treace Medical Concepts shares in Q2 2026, an estimated $158K.
- AllianceBernstein first reported a position in Treace Medical Concepts in Q2 2021 and held it in 20 quarters.
- AllianceBernstein's Treace Medical Concepts position peaked at $87.6M in Q2 2023.
- 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.